Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00517686
Status:
COMPLETED
Last Update Posted:
2012-08-03
First Post:
2007-08-15
Brief Title:
Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk FIT
Sponsor:
Kaiser Permanente
Organization:
Kaiser Permanente
Study Overview
Official Title:
Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk FIT
Status:
COMPLETED
Status Verified Date:
2012-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FIT
Brief Summary:
The primary research question of this study is to determine whether measuring reporting and feeding back information to primary care teams on the need for treatment intensification in patients at high risk for cardiovascular disease CVD can improve rates of treatment intensification and reduce levels of poorly controlled systolic blood pressure LDL-c and A1c
Detailed Description:
Project Description We propose a cluster randomized trial intervention involving eight or more medical facilities of Kaiser Permanente Northern California KP and more than 65000 patients at high risk for CVD At intervention facilities patient-level information obtained from KPs electronic health record on the need for treatment intensification for systolic blood pressure LDL-c and A1c and on recent medication adherence are added to a population management database and fed back through software currently used by staff working with primary care providers Staff at control facilities continue to use the same population management database and software but only receive information on risk factor levels and selected medications
Specific Aims
1 Evaluate the effectiveness of measurement and feedback of treatment intensification information in patients at high risk of CVD for improving rates of treatment intensification and for reducing levels of poorly controlled systolic blood pressure LDL-c and A1c
2 Evaluate the impact of the intervention compared with current practice on total numbers of patient contacts outpatient visits and costs of care in relation to improvements in risk factor control
3 Evaluate the effect of this innovation on physician and staff perceptions of the value effectiveness and efficiency of the population management program for high-risk patients
Relevance If this translational study shows that feedback of information on treatment intensification leads to higher rates of intensification and improved risk factor control this finding will have shown a population-level use of health information technology for improving clinical quality and will also have validated treatment intensification as a metric of clinical quality
Specific Aims
1 Evaluate the effectiveness of measurement and feedback of treatment intensification information in patients at high risk of CVD for improving rates of treatment intensification and for reducing levels of poorly controlled systolic blood pressure LDL-c and A1c
2 Evaluate the impact of the intervention compared with current practice on total numbers of patient contacts outpatient visits and costs of care in relation to improvements in risk factor control
3 Evaluate the effect of this innovation on physician and staff perceptions of the value effectiveness and efficiency of the population management program for high-risk patients
Relevance If this translational study shows that feedback of information on treatment intensification leads to higher rates of intensification and improved risk factor control this finding will have shown a population-level use of health information technology for improving clinical quality and will also have validated treatment intensification as a metric of clinical quality
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None